Jingwen Bai

Jingwen Bai

Auto-generated profile, based on publicly available information

Jingwen Bai

The Breast Center and the Cancer Institute of Yunnan Cancer Hospital, Yunnan Key Laboratory of Molecular Imaging in Oncology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
XWXiaolong Wei
Xiaolong Wei
DZDonghong Zhang
Donghong Zhang
XDXiaowei Dou
Xiaowei Dou
NNNa Niu
Na Niu
WHWenhe Huang
Wenhe Huang
GZGuojun Zhang
Guojun Zhang
Epoxyeicosatrienoic acids (EETs) are derived from arachidonic acid by cytochrome P450 (CYP) and metabolized by soluble epoxide hydrolase (sEH). EETs have been associated with cardiovascular disease, diabetes and several cancer diseases. However, the distribution in tissue and role of CYP2C8, 2C9, 2J2 and sEH in human breast carcinogenesis remains uncertain. Breast cancer (BC) and adjacent noncancerous tissue was obtained from 40 breast cancer patients in the Chaoshan region in China from 2010 to 2012. The level of 14,15-EET/14,15-DHET in BC patients was detected by ELISA; the expression and distribution of CYP2C8, 2C9, 2J2 and sEH was determined by quantitative RT-PCR and immunohistochemical staining; and cell proliferation and migration was analyzed by MTT and transwell assays, respectively. The median 14,15-EET and 14,15-EET/DHET level was 2.5-fold higher in BC than noncancerous tissue. The mRNA and protein levels of CYP2C8, 2C9 and 2J2 were higher, and sEH was lower in BC than noncancerous tissue. Furthermore, CYP2C8 and 2C9 protein levels positively correlated with Ki67 status, and CYP2J2 levels positively correlated with histological grade and tumor size. The sEH protein level negatively correlated with tumor size, estrogen receptors and Ki67. In MDA-MB-231 cells, siRNA knockdown of CYP2C8, 2C9 or 2J2 reduced cell proliferation, by 24.5%, 29.13%, or 22.7% and decreased cell migration by 49.1%, 44.9%, and 50.9%, respectively. Similarly, with adenovirus overexpression of sEH, both cell proliferation and migration rates were reduced by 31.4% and 45.8%, respectively. The present study shows that elevated EET levels in BC tissues are associated with upregulation of CYP2C8, 2C9, and 2J2, and downregulation of sEH, and are also associated with aggressive cell behavior in BC patients.

7 June 2023 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
MWMin Wei
Min Wei
XSXiao Shen
Xiao Shen
XFXueqi Fan
Xueqi Fan
JLJiwei Li
Jiwei Li
JBJingwen Bai
Jingwen Bai
Immune checkpoint blockade is now recognized as a paradigm-shifting cancer therapeutic strategy, whereas there remains difficulty in accurately predicting immunotherapy efficacy by PD-L1 expression. In addition, radiotherapy for cancer patients faces the problem of insufficient dose of radiotherapy at the tumor site while which have been not tolerated by normal tissues. In this study, we created PD-L1 aptamer-anchored spherical nucleic acids (SNAs) with a shell made of PD-L1 aptamer and indocyanine green (ICG) embedded in a mesoporous hafnium oxide nanoparticle core (Hf@ICG-Apt). Upon low pH irradiation in the tumor sites, the nano-system enabled the release of ICG in the high PD-L1 expression tumor to develop a high tumor-to-background ratio of 7.97 ± 0.76 and enhanced the ICG tumor retention to more than 48 h. Moreover, Hf@ICG-Apt improved radiation therapy (RT) when combined with radiation. Notably, Hf@ICG-Apt showed scarcely any systemic toxicity in vivo. Overall, this research offered a novel approach for applying reliable monitoring of PD-L1 expression and localization and robust RT sensitization against cancer with good biosafety.

7 February 2025 in Cancer Letters
Verified
Journal Article
Closed access
HCHongyu Chen
Hongyu Chen
LLLinling Lin
Linling Lin
ZQZishan Qiao
Zishan Qiao
YPYifei Pei
Yifei Pei
YGYiyang Gao
Yiyang Gao
GZGuojun Zhang
Guojun Zhang

24 October 2023 in Medcomm
Verified
Journal Article
Open access
JLJi‐Wei Li
Ji‐Wei Li
QDQiu‐Min Deng
Qiu‐Min Deng
JZJian‐Ling Zhu
Jian‐Ling Zhu
WMWei Min
Wei Min
XHXiao‐Yi Hu
Xiao‐Yi Hu
JBJing‐Wen Bai
Jing‐Wen Bai
Estrogen receptor α (ERα) serves as an essential therapeutic predictor for breast cancer (BC) patients and is regulated by epigenetic modification. Abnormal methylation of cytosine phosphoric acid guanine islands in the estrogen receptor 1 (ESR1) gene promoter could silence or decrease ERα expression. In ERα‐negative BC, we previously found snail family transcriptional repressor 2 (SNAI2), a zinc‐finger transcriptional factor, recruited lysine‐specific demethylase 1 to the promoter to transcriptionally suppress ERα expression by demethylating histone H3 lysine 4 dimethylation (H3K4me2). However, the role of SNAI2 in ERα‐positive BC remains elusive. In this study, we observed a positive correlation between SNAI2 and ESR1 methylation, and SNAI2 promoted ESR1 methylation by recruiting DNA methyltransferase 3 beta (DNMT3B) rather than DNA methyltransferase 1 (DNMT1) in ERα‐positive BC cells. Subsequent enrichment analysis illustrated that ESR1 methylation is strongly correlated with cell adhesion and junction. Knocking down DNMT3B could partially reverse SNAI2 overexpression‐induced cell proliferation, migration, and invasion. Moreover, high DNMT3B expression predicted poor relapse‐free survival and overall survival in ERα‐positive BC patients. In conclusion, this study demonstrated the novel mechanisms of the ESR1 methylation mediated with the SNAI2/DNMT3B complex and enhanced awareness of ESR1 methylation's role in promoting epithelial–mesenchymal transition in BC.

19 February 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
KLKang-Liang Lou
Kang-Liang Lou
JBJing-Wen Bai
Jing-Wen Bai
HLHong-Tan Liu
Hong-Tan Liu
LLLin-Ling Lin
Lin-Ling Lin
CLCheng-Xi Li
Cheng-Xi Li
GZGuojun Zhang
Guojun Zhang
In early breast cancer surgery (EBC), free margins significantly decrease local recurrence in breast-conserving surgery (BCS), while metastatic status of sentinel lymph node (SLN) impacts axillary management. However, intraoperative visualization of margins and metastatic SLNs (mSLNs) remains challenging. Here, we report a second-window near-infrared (NIR-II) fluorescence probe by conjugating ICG to TROP2-targeting cyclic peptide (TTP-ICG). Our results showed that TTP-ICG specifically binds to TROP2-expressing cells in vitro and identifies TROP2-positive tumors in vivo. In addition, TTP-ICG enabled efficient intraoperative evaluation of surgical margins and visualization of mSLNs at a submillimeter level in preclinical models. Additionally, we optimized the rapid incubation imaging method (RIIM) by shortening the procedure to less than 8 min, illustrating TTP-ICG’s high performance in distinguishing malignant from normal tissues/fibroadenoma lesions as well as detecting metastatic lymph nodes in a cohort of 59 patients. Thus, this TROP2-targeting probe demonstrates its significance for fluorescence imaging-guided surgery with dual applicability in EBC, providing translational potential for further clinical decision-making.

10 October 2025 in International Journal of Surgery
Verified
Journal Article
Open access
XFXue-Qi Fan
Xue-Qi Fan
JBJing-Wen Bai
Jing-Wen Bai
SYShi-Long Yu
Shi-Long Yu
XSXiao Shen
Xiao Shen
LNLei Niu
Lei Niu
GZGuojun Zhang
Guojun Zhang
Background: Near-infrared fluorescence (NIRF) imaging with indocyanine green (ICG) is widely employed for sentinel lymph node (SLN) biopsy in breast cancer but cannot assess SLN metastatic status. Current intraoperative assessment relies on frozen section (FS) analysis, which is time-consuming, causes tissue loss, and suffers from limited sensitivity with a high false-negative rate (FNR). Materials and Methods: Preclinical data included fluorescence images from 4T1-Luc and MDA-MB-231-Luc mouse lymph node metastasis models. Clinical data comprised 35 breast cancer patients in a prospective clinical trial (NCT05623280). Intraoperative ICG-based NIRF imaging was performed, and four convolutional neural networks (Vgg19, Efficientnet, Resnet, and Densenet) were evaluated. Results: In the mouse test set, the proposed approach achieved an area under the receiver operating characteristic curve (AUC) of 0.799 (95% confidence interval [CI]: 0.787–0.810) for cohort 1 and 0.804 (95% CI: 0.793–0.816) for cohort 2. In the clinical cohort comprising 35 patients and 114 excised SLNs (16 metastatic and 98 non-metastatic), it demonstrated robust performance in detecting metastatic SLNs, with an AUC of 0.898 (95% CI: 0.892–0.903). The LymphNet approach, which aggregates predictions from multiple SLN images, yielded an FNR of 18.75%, comparable to FS analysis (FNR: 13.5–31.3%). LymphNet avoids tissue loss and streamlines the workflow, with the model’s prediction process requiring less than 10 s. For the first time, we observed a marked reduction or complete absence of fluorescence in metastatic SLNs infiltrated by breast cancer cells. Conclusion: This study establishes a novel, efficient tool for intraoperative SLN metastatic assessment.